Targeting the adaptive immune system: new strategies in the treatment of atherosclerosis

Area of Science:

• Cardiovascular Biology
• Immunology
• Pharmacology

Background:

• Atherosclerosis is a chronic inflammatory disease driven by lipids in the arterial wall.
• Current treatments primarily manage risk factors like hyperlipidemia and hypertension.
• Therapies targeting the inflammatory component of atherosclerosis are still under development.

Purpose of the Study:

• To review drug targets involved in the adaptive immune system's role in atherosclerosis.
• To discuss the therapeutic potential of these novel targets for modulating the disease.

Main Methods:

• Literature review of studies on immune system targets in atherosclerosis.
• Analysis of the adaptive immune system's involvement in arterial wall inflammation.
• Evaluation of potential drug targets for therapeutic intervention.

Main Results:

• Identified key drug targets within the adaptive immune system crucial to atherosclerosis.
• Highlighted the inflammatory pathways implicated in disease progression.
• Discussed the translational potential of these targets for new drug development.

Conclusions:

• Novel therapeutic strategies for atherosclerosis can be developed by targeting the adaptive immune system.
• Understanding immune mechanisms offers new avenues for treating this chronic inflammatory condition.
• Further research into these targets may lead to more effective atherosclerosis modulation.